Study #2023-0864
A pilot study of Emapalumab for the treatment of CAR T-Cell therapy-associated prolonged cytopenia
MD Anderson Study Status
Enrolling
Treatment Agent
Emapalumab
Description
To look at the safety and effectiveness of emapalumab for the treatment of prolonged severe cytopenia in participants with LBCL who receive CART.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cytopenia
Study phase:
Phase II
Physician name:
Paolo Strati
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-833-731-1107
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.